+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Statin use after diagnosis is associated with an increased survival in esophageal cancer patients: a Belgian population-based study



Statin use after diagnosis is associated with an increased survival in esophageal cancer patients: a Belgian population-based study



Cancer Causes and Control 2019



Preclinical studies have shown that statins reduce proliferation in esophageal cancer. Three recent observational studies have shown encouraging results but suffered from limitations. This work aimed to assess at the Belgian population level whether statin usage was associated with a decreased mortality in esophageal cancer patients. We conducted an observational, population-based study by linking data of the Belgian Cancer Registry (BCR) with medical claims data coming from health insurance companies and mortality records collected by regional governments for patients diagnosed with esophageal cancer between 2004 and 2014. Using time-dependent Cox regression models, hazard ratios (HRs) and 95% confidence intervals (CI) for overall and cancer-specific mortality were calculated. Of 6,238 patients with stage I-III esophageal cancer, post-diagnostic use of statins was found in 1,628 (26%) patients. Statins use after diagnosis was associated with a reduction in overall mortality (adjusted HR = 0.84, 95% CI [0.77; 0.92]) and cancer-specific mortality (adjusted HR = 0.87, 95% CI [0.78; 0.97]). Similar association were also seen for pre-diagnostic statin use in overall (adjusted HR = 0.83, 95% CI [0.76-0.91]) and cancer-specific analysis (adjusted HR = 0.86, 95% CI [0.77-0.96]). In this large cohort of Belgian patients with esophageal cancer, statins use after diagnosis was associated with a decreased mortality.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 066545098

Download citation: RISBibTeXText

PMID: 30820714

DOI: 10.1007/s10552-019-01149-3


Related references

Statin use after esophageal cancer diagnosis and survival: A population based cohort study. Cancer Epidemiology 48: 124-130, 2017

Association Between Statin Use After Diagnosis of Esophageal Cancer and Survival: A Population-Based Cohort Study. Gastroenterology 150(4): 854-65.E1; Quiz E16-7, 2016

Increased resection rates and survival among patients aged 75 years and older with esophageal cancer: a Dutch nationwide population-based study. World Journal of Surgery 36(12): 2872-2878, 2013

Statin use after diagnosis of breast cancer and survival: a population-based cohort study. Epidemiology 26(1): 68-78, 2015

Statin use after colorectal cancer diagnosis and survival: a population-based cohort study. Journal of Clinical Oncology 32(28): 3177-3183, 2014

Impact of diagnosis-to-treatment waiting time on survival in esophageal cancer patients - A population-based study in The Netherlands. European Journal of Surgical Oncology 43(2): 461-470, 2016

Statin improves survival in patients with EGFR-TKI lung cancer: A nationwide population-based study. Plos One 12(2): E0171137, 2017

Statin use and the risk of esophageal cancer: a population-based case-control study. Expert Opinion on Drug Safety 12(3): 293-298, 2013

Dynamics of observed and relative survival of esophageal cancer patients (population-based study). Voprosy Onkologii 59(2): 41-46, 2013

Influence of socioeconomic environment on survival in patients diagnosed with esophageal cancer: a population-based study. Diseases of the Esophagus 25(8): 723-730, 2013

Statin use and survival from lung cancer: a population-based cohort study. Cancer Epidemiology, Biomarkers and Prevention 24(5): 833-841, 2016

The influence of marital status on the survival of patients with esophageal cancer: a population-based, propensity-matched study. Oncotarget 8(37): 62261-62273, 2017

Statin use and survival in patients with gastric cancer in two independent population-based cohorts. Pharmacoepidemiology and Drug Safety 2018, 2018

Statin use is associated with improved survival in ovarian cancer: A retrospective population-based study. Plos One 12(12): E0189233, 2018

Survival after definitive (chemo)radiotherapy in esophageal cancer patients: a population-based study in the north-East Netherlands. Annals of Surgical Oncology 20(6): 1985-1992, 2013